ここから本文です

Form 8-K(January 9, 2026)
ongoing Phase3
・PREVAIL study(NCT05202509)
 Primary Completion 2026-11*
・REMBRANDT study(NCT06305559)
 Primary Completion 2026-12*
・RUBENS study(NCT07219602)
 Not yet recruiting
 Primary Completion 2028-03*

completed Phase3
・BROOKLYN study(NCT05425745)
 Study Completion 2024-05-28
・BROADWAY study(NCT05142722)
 Study Completion 2024-09-26
・TANDEM study(NCT06005597)
 Study Completion 2024-10-16

*Estimated

投資の参考になりましたか?